“The abortionist who sends these drugs is shielded from prosecution by his state, but is breaking the law of the state where the woman resides,” wrote Steupert. “In 2024, shield laws allowed for 76,310 abortion drug regimens to be sent to women in states with full nine-month protections, 25,180 into states with 6-week limits, and 19,340 to women in states with telehealth restrictions.”
The study found that three international online organizations, Telefem Mexico, Abortion Pill in Private, and Women on the Web “provide non-FDA-approved drugs manufactured outside of the FDA’s approved supply chain.”
Steupert characterized the landscape of acquiring abortion drugs outside the U.S. health care system as the “wild west” with virtually “zero safeguards” in place on international e-commerce websites or community networks. She also noted that that even within the U.S. healthcare system, many telehealth providers fall short of the standards and regulations typically associated with telehealth services.
“Federal law prohibits the mailing of abortion drugs within the formal U.S. healthcare system and the importation of unapproved abortion drugs outside of the formal healthcare system,” wrote Steupert. “However, the federal government hasn’t enforced these laws.”
Liberty Counsel Founder and Chairman Mat Staver said, “Abortion pills harm women and cruelly kill innocent unborn children in the womb. Whether it is Mifepristone or unbranded or misbranded drugs, trafficking abortion pills through the mail or beyond gestation limits, especially to pro-life states, is illegal under federal and state laws. The FDA should revoke Mifepristone’s safety approval, and the Comstock Act must be enforced.”